Home > Insider Trading > Filing (0000200406-12-000144)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
200406	Johnson & Johnson	JNJ	Pharmaceutical Preparations (2834)	221024240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1142630	James Cullen	Johnson &Amp; Johnson One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-11-12	6,300	$52.20	14,704	No	4	M	Direct
Common Stock	Disposition	2012-11-12	7,600	$53.93	22,304	No	4	M	Direct
Common Stock	Disposition	2012-11-12	13,900	$69.70	8,404	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Deferred Share Units	Acquisiton	2012-09-30	901	$0.00	901	$0.00
Common Stock	Non-Employee Director Stock Options (Right to Buy)	Disposition	2012-11-12	6,300	$0.00	6,300	$52.20
Common Stock	Non-Employee Director Stock Options (Right to Buy)	Disposition	2012-11-12	7,600	$0.00	7,600	$53.93

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
33,415			No	4	A	Direct
0	2004-02-11	2013-02-08	No	4	M	Direct
0	2005-02-10	2014-02-07	No	4	M	Direct

Footnotes

Includes 282 shares held under Issuer's Dividend Reinvestment Plan.
The dividends accrued as Deferred Share Units under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).
Awarded under the Stock Option Plan for Non-Employee Directors and exercisable in full one day after the first anniversary of the grant.